<DOC>
	<DOCNO>NCT01892254</DOCNO>
	<brief_summary>This study investigate incretin effect woman polycystic ovary syndrome ( PCOS ) removal insulin resistance metformin . The investigator ' hypothesis insulin resistant woman PCOS reduce incretin effect elevate glucagon response measure 75-g oral glucose tolerance test isoglycemic i.v . glucose infusion . The investigator hypothesise improve insulin resistance remove .</brief_summary>
	<brief_title>Incretin Effect PCOS Women</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>Inclusion Criteria PCOSwomen : Diagnosed PCOS accord Rotterdam criterion 18 year old BMI le 30 kg/m2 Normal glucose tolerance fast plasma glucose ( assessed 75g OGTT ) Negative GAD65 islet cell autoantibody Insulin resistant accord HOMAIR informed consent Inclusion Criteria healthy woman : 18 year old BMI le 30 kg/m2 Normal glucose tolerance fast plasma glucose ( assessed 75g OGTT ) Negative GAD65 islet cell autoantibody inform consent regular menstrual cycle ( 2835 day ) Plasma androgen level within reference level Exclusion Criteria PCOS healthy woman : First second degree relative diabetes pregnancy breast feed treatment medication influence glucose metabolism ( incl hormonal contraception ) Congenital diseases cause hyperandrogenism irregular bleed Known adrenal hyperplasia Known hyperprolaktinemia Alcohol consumption 20 gram day Hemoglobin le 7.8 %</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>incretin effect</keyword>
	<keyword>PCOS</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>OGTT</keyword>
	<keyword>IIGI</keyword>
</DOC>